
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Crying and irritability are nonspecific complaints whose etiologies in a nonverbal child are often obscure. Therefore, a thorough history and a careful physical examination, combined with selected diagnostic tests, are crucial in arriving at an accurate diagnosis.






